Back to dashboard
MedicaidCoverageMedium impact

Senior Services News Vol. 26, No. 02

New Jersey Medicaid·NJ·Pharmacy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

GlaxoSmithKline (GSK) and Eli Lilly are withdrawing from New Jersey's PAAD and Senior Gold prescription assistance programs. This affects medication coverage for elderly and disabled patients in New Jersey who rely on these state assistance programs.

Action Required

Action needed
Immediately: Billing and clinical staff should identify patients currently using GSK or Eli Lilly medications covered under New Jersey PAAD and Senior Gold programs. Contact these patients to discuss alternative medication options or assistance programs. Update patient medication lists and verify coverage with alternative payers before dispensing affected medications.

Related policy hubs